Reorienting catch-up growth research toward early-life prevention of metabolic disorders using natural products
By
Hendra Stevani
Habibie Habibie
Asbah Asbah
Firzan Nainu
May 28, 2026
Clinical Scorecard: Shifting Focus of Catch-Up Growth Studies to Early-Life Prevention of Metabolic Disorders Through Natural Products
At a Glance
Category Detail
Condition Catch-up growth and associated metabolic disorders, including insulin resistance and type 2 diabetes Key Mechanisms Target Population Care Setting
Key Highlights
Excessive post-stunting growth linked to insulin resistance and type 2 diabetes Early-life is a critical window for metabolic programming and prevention Natural products may offer safe and effective interventions for metabolic dysfunction Addressing both nutritional needs and metabolic quality is essential. Guideline-Based Recommendations
Diagnosis
Management
Implement nutritional strategies that prioritize metabolic quality, such as increasing fiber intake and reducing processed sugars Consider bioactive compounds like polyphenols and flavonoids for metabolic modulation Monitoring & Follow-up
Risks
Patient & Prescribing Data
Early exposure to bioactive compounds may influence metabolic programming and reduce the risk of later metabolic disorders.
Clinical Best Practices
Reframe catch-up growth as a metabolically sensitive period for intervention Address both nutritional needs and metabolic quality in treatment plans Monitor metabolic health indicators such as insulin sensitivity and body composition changes. Related Resources & Content
